Tercica Medica Inc is categorized under Commercial Biotechnical Research in Brisbane, CA and active since 2008.
Tercica Medica Inc was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Shalini Goyal at the company’s single location by writing to 2000 Sierra Point Parkway # 400, Brisbane, California CA 94005 or by phoning (650) 238-0002. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Tercica Medica Inc |
| Contact Person: | Shalini Goyal |
| Address: | 2000 Sierra Point Parkway # 400, Brisbane, California 94005 |
| Phone Number: | (650) 238-0002 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Tercica Medica Inc was started in 2008 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Shalini Goyal for inquiries that concern Tercica Medica Inc by calling the company number (650) 238-0002, as your correspondence is most welcome. Additionally, the physical location of the single location of Tercica Medica Inc can be found at the coordinates 37.674054,-122.384638 as well as the street address 2000 Sierra Point Parkway # 400 in Brisbane, California 94005.
For its online presence, you may visit Tercica Medica Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.